Trueblue, Inc. (TBI) Dividend History

Company News

• Recruitment Process Outsourcing Market to Witness 16.1% CAGR by 2031 | SkyQuest Technology

  The Recruitment Process Outsourcing (RPO) market is projected to grow significantly, reaching USD 28.09 Billion by 2031 at a CAGR of 16.1%. The market is driven by the rising demand for scalable and efficient hiring solutions, as well as the increasing adoption of advanced recruitment technologies like AI and automation.

  GlobeNewswire Inc.

  Featured Companies: ADP HSON IBM KFY MAN
• Zacks Industry Outlook Highlights Heidrick & Struggles International, TrueBlue and RCM Technologies

  Heidrick & Struggles International, TrueBlue and RCM Technologies are part of the Zacks Industry Outlook article.

  Zacks Investment Research

  Featured Companies: HSII RCMT
• These small-cap managers’ stock picks crushed the indexes last year — again. Here’s what they’re buying now.

  These are the picks from a pair of the best small-cap stock pickers you've probably never heard of.

  MarketWatch

  Featured Companies: AAP AVA CRI DOX IWM KELYA MNRO PHYS PSLV WLY
• Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations

  U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Tuesday. The Dow traded up 0.67% to 33,155.68 while the NASDAQ rose 0.78% to 13,120.31. The S&P 500 also rose, gaining, 0.72% to 4,247.52. Check This Out: 'Never Buy A Drug Stock Just For The Yield': Jim Cramer On This Big Pharma Company   Leading and Lagging Sectors   Utilities shares rose by 2.6% on Tuesday. In trading on Tuesday, energy shares fell by 1%.   Top Headline   The Coca-Cola Company (NYSE: KO) reported better-than-expected third-quarter financial results and raised full-year guidance. Coca-Cola reported third-quarter FY23 sales growth of 8% year-on-year to $11.95 billion, beating the analyst consensus estimate of $11.44 billion. Adjusted EPS of $0.74 beat the analyst consensus estimate of $0.69. Coca-Cola raises FY23 organic revenue growth outlook from 8% - 9% to 10% - 11%. The company sees comparable currency neutral EPS growth of 13%-14% (prior 9%-11%).   Equities Trading UP   InMed Pharmaceuticals Inc. (NASDAQ: INM) shares shot up 141% to $1.3999 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data. Shares of Agilysys, Inc. (NASDAQ: AGYS) got a boost, shooting ...

  Benzinga

  Featured Companies: AGYS INM KO TRU
• TrueBlue (TBI) Q2 2022 Earnings Call Transcript

  TBI earnings call for the period ending June 30, 2022.

  The Motley Fool